33915500|t|Are dexmedetomidine and olanzapine suitable to control delirium in critically ill elderly patients? A retrospective cohort study.
33915500|a|BACKGROUND: The efficacy and safety of dexmedetomidine and olanzapine for delirium control in critically ill elderly patients without ventilation or surgery are not known. METHODS: The efficacy and safety of dexmedetomidine and olanzapine for controlling delirium were evaluated in a retrospective cohort of critically illness by assessing the sedation level, drug dose/duration, combination rate with other sedatives, adverse effects, intubation rate and prognosis. RESULT: The maximum (1.61 +- 1.56 vs. 2.70 +- 1.01, p < 0.001), average (-0.57 +- 0.88 vs. 0.88 +- 0.73, p < 0.001), and minimum (-1.67 +- 1.04 vs. -1.37 +- 1.01, p = 0.014) RASS scores of 263 patients were lower after treating with dexmedetomidine than treating with olanzapine. Drug use duration (4.83 +- 2.67 days vs. 5.87 +- 3.14 days, p = 0.005) and sedative combination rates (13.56% vs. 40.00%, p = 0.003) were lower when treating with dexmedetomidine than that with olanzapine. A comparison of adverse effects between dexmedetomidine and olanzapine revealed respiratory depression (16.95% vs. 2.84%, p < 0.001), hypoxia (13.56% vs. 2.76%, p < 0.001) and hypotension (11.02% vs. 3.45%, p = 0.007). Intubation rates (22.88% vs. 12.41%, p = 0.023) and the length of hospital stay (9.30 +- 4.90 days vs. 8.83 +- 3.34 days, p < 0.001) were higher in patients treated with dexmedetomidine than that with olanzapine. Mortality rates, cognitive prognosis, and delirium recurrence rates were similar between groups. Age, severe cardiopulmonary disease, APACHE II scores, dexmedetomidine dose, minimum RASS score and sedative combination were significantly (p < 0.05) associated with the adverse effects of dexmedetomidine. Respiratory depression, hypoxia and hypotension in the olanzapine group all occurred during combination with benzodiazepines. CONCLUSIONS: Dexmedetomidine achieved more satisfactory sedative effects on delirium control, but olanzapine was safer.
33915500	4	19	dexmedetomidine	Chemical	MESH:D020927
33915500	24	34	olanzapine	Chemical	MESH:D000077152
33915500	55	63	delirium	Disease	MESH:D003693
33915500	67	81	critically ill	Disease	MESH:D016638
33915500	90	98	patients	Species	9606
33915500	169	184	dexmedetomidine	Chemical	MESH:D020927
33915500	189	199	olanzapine	Chemical	MESH:D000077152
33915500	204	212	delirium	Disease	MESH:D003693
33915500	224	238	critically ill	Disease	MESH:D016638
33915500	247	255	patients	Species	9606
33915500	338	353	dexmedetomidine	Chemical	MESH:D020927
33915500	358	368	olanzapine	Chemical	MESH:D000077152
33915500	385	393	delirium	Disease	MESH:D003693
33915500	438	456	critically illness	Disease	MESH:D016638
33915500	790	798	patients	Species	9606
33915500	830	845	dexmedetomidine	Chemical	MESH:D020927
33915500	865	875	olanzapine	Chemical	MESH:D000077152
33915500	1040	1055	dexmedetomidine	Chemical	MESH:D020927
33915500	1071	1081	olanzapine	Chemical	MESH:D000077152
33915500	1123	1138	dexmedetomidine	Chemical	MESH:D020927
33915500	1143	1153	olanzapine	Chemical	MESH:D000077152
33915500	1163	1185	respiratory depression	Disease	MESH:D012131
33915500	1217	1224	hypoxia	Disease	MESH:D000860
33915500	1259	1270	hypotension	Disease	MESH:D007022
33915500	1450	1458	patients	Species	9606
33915500	1472	1487	dexmedetomidine	Chemical	MESH:D020927
33915500	1503	1513	olanzapine	Chemical	MESH:D000077152
33915500	1557	1565	delirium	Disease	MESH:D003693
33915500	1624	1647	cardiopulmonary disease	Disease	MESH:D006323
33915500	1667	1682	dexmedetomidine	Chemical	MESH:D020927
33915500	1802	1817	dexmedetomidine	Chemical	MESH:D020927
33915500	1819	1841	Respiratory depression	Disease	MESH:D012131
33915500	1843	1850	hypoxia	Disease	MESH:D000860
33915500	1855	1866	hypotension	Disease	MESH:D007022
33915500	1874	1884	olanzapine	Chemical	MESH:D000077152
33915500	1928	1943	benzodiazepines	Chemical	MESH:D001569
33915500	1958	1973	Dexmedetomidine	Chemical	MESH:D020927
33915500	2021	2029	delirium	Disease	MESH:D003693
33915500	2043	2053	olanzapine	Chemical	MESH:D000077152
33915500	Positive_Correlation	MESH:D020927	MESH:D012131
33915500	Positive_Correlation	MESH:D020927	MESH:D007022
33915500	Comparison	MESH:D000077152	MESH:D020927
33915500	Negative_Correlation	MESH:D000077152	MESH:D016638
33915500	Negative_Correlation	MESH:D000077152	MESH:D001569
33915500	Positive_Correlation	MESH:D000077152	MESH:D000860
33915500	Negative_Correlation	MESH:D020927	MESH:D016638
33915500	Negative_Correlation	MESH:D001569	MESH:D020927
33915500	Negative_Correlation	MESH:D000077152	MESH:D003693
33915500	Positive_Correlation	MESH:D020927	MESH:D000860
33915500	Negative_Correlation	MESH:D020927	MESH:D003693
33915500	Positive_Correlation	MESH:D000077152	MESH:D007022
33915500	Positive_Correlation	MESH:D000077152	MESH:D012131

